Key points are not available for this paper at this time.
It is anticipated that combination therapy strategies will be the way forward for immunotherapy in breast cancer, with an improved understanding of tumor, microenvironment, and host factors informing treatment combination decisions. Thoughtful study design incorporating appropriate end points and correlative studies will be critical in identifying optimal strategies for enhancing the immune response against breast tumors.
Building similarity graph...
Analyzing shared references across papers
Loading...
Adams et al. (Fri,) studied this question.
synapsesocial.com/papers/69da23f8b48bb130d4684368 — DOI: https://doi.org/10.1001/jamaoncol.2018.7147
Sylvia Adams
NYU Langone Health
Margaret E. Gatti‐Mays
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Kevin Kalinsky
Emory University
JAMA Oncology
Brigham and Women's Hospital
University of North Carolina at Chapel Hill
Dana-Farber Cancer Institute
Building similarity graph...
Analyzing shared references across papers
Loading...